Takeda Pharmaceuticals USA, Inc. Data Breach – Investigated by Federman & Sherwood
June 29, 2026 – Federman & Sherwood, a national consumer protection law firm, is investigating the Takeda Pharmaceuticals data breach, a cybersecurity incident involving unauthorized access to sensitive personal information that was reported to the Attorney General of Texas.
According to the filing, the Takeda Pharmaceuticals data breach affected approximately 392 Texas residents. The information potentially exposed includes names, addresses, Social Security numbers, driver’s license numbers, government-issued identification numbers, medical information, and dates of birth.
Healthcare and pharmaceutical companies maintain highly sensitive patient, employee, and business information. The exposure of this combination of personal and medical information may increase the risk of identity theft, medical identity theft, insurance fraud, and other forms of misuse.
Federman & Sherwood is actively investigating whether Takeda Pharmaceuticals USA, Inc. implemented reasonable cybersecurity safeguards to protect sensitive personal information and whether this data security incident could have been prevented. The firm is also evaluating potential legal claims on behalf of individuals affected by the Takeda Pharmaceuticals data breach.
The filing indicates that affected individuals were notified by U.S. Mail.
Consumers who received a notice regarding the Takeda Pharmaceuticals data breach or who believe their personal information may have been compromised are encouraged to monitor healthcare records, explanation of benefits statements, financial accounts, and credit reports for suspicious activity.
The potentially compromised information may include:
- Names
- Social Security numbers
- Dates of birth
- Addresses
- Driver’s license numbers
- Medical information
- Other sensitive information
What is Takeda Pharmaceuticals USA, Inc.?
Takeda Pharmaceuticals USA, Inc. is a biopharmaceutical company focused on researching, developing, and delivering life-transforming treatments.
Individuals affected by the Takeda Pharmaceuticals data breach may have legal rights and are encouraged to contact Federman & Sherwood to learn more about their options.
Phone: 1-800-237-1277 | Email: info@federmanlaw.com